상급종합병원, 코로나바이러스감염증-19 음압격리병동에서 약사의 역할 보고
Report on the Role of Pharmacist in Communicable Disease Isolation Unit of a Tertiary Teaching Hospital
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background : Due to the COVID-19 pandemic, the importance of monitoring antimicrobial use is increasing. The role of pharmacists for personalized medication considering the latest drug information and patient clinical conditions is very important. So far, no Korean research has reported the role of pharmacists participating as a member of multidisciplinary team in communicable disease isolation units (CDIU) during the novel infectious disease pandemic. Methods : Clinical data with personal information deleted were reviewed retrospectively. The role of clinical pharmacists in infectious diseases was examined by analyzing pharmaceutical services provided by clinical pharmacists at a CDIU in a tertiary teaching hospital. Results : Key pharmaceutical services provided by clinical pharmacist had five categories: evidence-based treatment, clinical pathway development, drug formula and shortage management, multidisciplinary team member, and prospective evaluation of drug therapy. Conclusion : This report confirmed the role of pharmacists having a good understanding of drug treatment as essential members in the multidisciplinary team. It is meaningful in that we report the possibility of expanding clinical pharmacists’ professional functions in Korea for the first time.
Abstract
Background : Due to the COVID-19 pandemic, the importance of monitoring antimicrobial use is increasing. The role of pharmacists for personalized medication considering the latest drug information and patient clinical conditions is very important. So far, no Korean research has reported the role of pharmacists participating as a member of multidisciplinary team in communicable disease isolation units (CDIU) during the novel infectious disease pandemic. Methods : Clinical data with personal information deleted were reviewed retrospectively. The role of clinical pharmacists in infectious diseases was examined by analyzing pharmaceutical services provided by clinical pharmacists at a CDIU in a tertiary teaching hospital. Results : Key pharmaceutical services provided by clinical pharmacist had five categories: evidence-based treatment, clinical pathway development, drug formula and shortage management, multidisciplinary team member, and prospective evaluation of drug therapy. Conclusion : This report confirmed the role of pharmacists having a good understanding of drug treatment as essential members in the multidisciplinary team. It is meaningful in that we report the possibility of expanding clinical pharmacists’ professional functions in Korea for the first time.
참고문헌 (22)
- Zhu N, "A Novel Coronavirus from Patients with Pneumonia in China, 2019", N Engl J Med, 382(8), pp.727~733 (2020)
- Cucinotta D, "WHO Declares COVID-19 a Pandemic", Acta Biomed, 91(1), pp.157~160 (2020)
- Ita K, "Coronavirus Disease(COVID-19) : Current Status and Prospects for Drug and Vaccine Development", Arch Med Res, 52(1), pp.15~24 (2021)
- Bragazzi NL, "The Role of Hospital and Community Pharmacists in the Management of COVID-19: Towards an Expanded Defi-nition of the Roles, Responsibilities, and Duties of the Pharmacist", Pharmacy (Basel), 8(3) (2020)
- 정정원, "외과계 중환자실 약사의 처방중재효과 평가", 병원약사회지, 31(4), pp.908~918 (2014), 한국병원약사회[DOI]
- 신상미, "외과계 중환자실 전담약사 유무에 따른 중재활동 변화 및 회피비용 분석", 병원약사회지, 34(4), pp.401~409 (2017), 한국병원약사회[DOI]
- Gil-Navarro MV, "Hospital Pharmacy in the multidisciplinary team of COVID inpatient units", Farm Hosp, 44(7), pp.40~42 (2020)
- Visacri MB, "Role of pharmacist during the COVID-19pandemic : A scoping review", Res Social Adm Pharm, 17(1), pp.1799~1806 (2021)
- Eun-Joong Kim, "코로나바이러스: 사스, 메르스 그리고 코비드-19", 대한임상검사과학회지, 52(4), pp.297~309 (2020), 대한임상검사과학회[DOI]
- Suh Hyeon Jeong, "Clinical Characteristics of COVID-19: Risk Factors for Early Oxygen Requirement after Hospitalization", Journal of Korean Medical Science, 36(19), pp.1~7 (2021), 대한의학회[DOI]
- Song J, "Clinical course and risk factors of fatal adverse outcomes in COVID-19 patients in Korea : a nationwide retrospective cohort study", Sci Rep, 11(1), pp.10066~ (2021)
- Cascella M, "StatPearls" (2021), StatPearls Publishing
- 손유민, "중환자실 임상약사의 약물처방 검토 시 필요한 필수점검 항목 개발", 병원약사회지, 36(1), pp.26~46 (2019), 한국병원약사회[DOI]
- Preslaski CR, "Pharmacist contributions as members of the multidisciplinary ICU team", Chest, 144(5), pp.1687~1695 (2013)
- Lat I, "Position Paper on Critical Care Pharmacy Services : 2020 Update", Crit Care Med, 48(9), pp.e813~e834 (2020)
- Horby P, "Dexamethasone in Hospitalized Patients with Covid-19", N Engl J Med, 384(8), pp.693~704 (2021)
- Kalil AC, "Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19", N Engl J Med, 384(9), pp.795~807 (2021)
- Rosas IO, "Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia", N Engl J Med, 384(16), pp.1503~1516 (2021)
- Kane SL, "The impact of critical care pharmacists on enhancing patient outcomes", Intensive Care Med, 29(5), pp.691~698 (2003)
- Stollings JL, "Critical Care Pharmacists and Medication Management in an ICU Recovery Center", Ann Pharmacother, 52(8), pp.713~723 (2018)
- Erstad BL, "Interdisciplinary patient care in the intensive care unit : focus on the pharmacist", Pharmacotherapy, 31(2), pp.128~137 (2011)
- Ahjel SW, "The Pharmacist’s Missing Role in the COVID-19Pandemic", Innov Pharm., 11(2) (2020)